Skip to Content

Join the 'Gastric Cancer' group to help and get support from people like you.

Gastric Cancer News

Highly Processed Foods Tied to Higher Cancer Risk

Posted 15 Feb 2018 by Drugs.com

WEDNESDAY, Feb. 14, 2018 – If you worry about ever getting cancer, you might want to pass on the processed foods at your supermarket. Every 10 percent dietary increase in packaged snacks, fizzy drinks, sugary cereals and other highly processed foods boosts the risk for cancer by 12 percent, new research suggests. Breast cancer, in particular, was associated with greater consumption of ...

'One-Stop' Blood Test for Cancer Shows Early Promise

Posted 18 Jan 2018 by Drugs.com

THURSDAY, Jan. 18, 2018 – In an early step toward "one-stop" screening for cancer, researchers report they've developed a blood test that can detect eight types of the disease. The blood test is dubbed CancerSEEK. It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. The accuracy range was better – 69 percent to 98 percent – when it came ...

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps ...

FDA Approves Merck’s Keytruda (pembrolizumab) for Previously Treated Patients with Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Whose Tumors Express PD-L1

Posted 25 Sep 2017 by Drugs.com

KENILWORTH, N.J.--(BUSINESS WIRE) September 22, 2017 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) therapy, for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal j ...

Cancer Takes Financial Toll, Even With Insurance

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Many cancer patients in the United States are shocked by their out-of-pocket costs for care – with some spending one-third of their income on treatment, a new study finds. The study looked at the financial toll of cancer treatment on people who have health insurance. The vast majority in the study had private insurance or Medicare coverage; the rest were on Medicaid, ...

Gum Disease May Be Linked to Cancer Risk in Older Women

Posted 1 Aug 2017 by Drugs.com

TUESDAY, Aug. 1, 2017 – A new study links gum disease with an increased risk of several types of cancer in postmenopausal women, even in women who never smoked. So-called periodontal disease was tied to a 14 percent higher risk of developing any type of cancer, the investigators found. But the greatest risk was for esophageal cancer, which was more than three times more likely in older women who ...

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris ...

Insured, But Still Barred From Top-Tier Cancer Centers

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive "narrow network" health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis. "We found that the narrower networks were more ...

More Patients OK'd for Cancer Trials Under Obamacare: Study

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – The Affordable Care Act has enabled more privately insured patients to enroll in clinical trials for new cancer treatments, a new study contends. Speedy approvals are important for patients who want to participate in clinical trials, said study author Dr. David Hong. He's deputy chair of investigational cancer therapeutics at the University of Texas MD Anderson Cancer ...

Many Terminal Cancer Patients Remain in Denial

Posted 20 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should ...

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In ...

2 of 3 Americans Don't Have 'Advance Directive' for End of Life

Posted 7 Jul 2017 by Drugs.com

FRIDAY, July 7, 2017 – Most people don't like talking about dying, especially their own death. But it's important to let your loved ones know how you'd like your medical care handled when your "time" comes. Yet, new research found that two-thirds of American adults haven't completed an advance directive. That's a legal document that outlines a person's wishes if they become incapacitated and ...

Do Blacks, Hispanics Get Low Quality Hospice Care?

Posted 6 Jul 2017 by Drugs.com

WEDNESDAY, July 5, 2017 – Hospice quality varies, with blacks and Hispanics often getting less desirable end-of-life care, a new study finds. Researchers surveyed thousands of caregivers whose loved ones died in hospice care. They found that minority patients were more likely to receive care in poorer quality hospices than white patients. They also said that family caregivers of black and ...

Big Gap in Cancer Deaths Between Rich, Poor Countries

Posted 22 Jun 2017 by Drugs.com

WEDNESDAY, June 21, 2017 – Over the past few decades, death rates linked to cancer and heart disease have declined in most developed nations, thanks to more effective prevention strategies, early detection and greater access to quality health care. But the same isn't true for poorer counties where the number of people dying from cancer has either remained unchanged or continues to rise, ...

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, ...

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, Herceptin, Keytruda, Taxotere, pembrolizumab, Cyramza, docetaxel, ramucirumab, trastuzumab, Ogivri